Brind.

UBS questioned Dentsply Sirona regarding the sustainability of its EBIT margins and growth durability in the German market.

1 report, 0 independent Updated Jun 27

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Dentsply Sirona UBS

Keep exploring

The entities involved

Dentsply Sirona
American dental equipment maker and dental consumables producer
- Dental equipment industry competition involving Dentsply Sirona, Align Technology, Nobel Biocare, and Henry Schein.Thu 13:21
- Dentsply Sirona and Align Technology are navigating industry-wide soft demand for dental equipment.Thu 13:21
UBS
Swiss multinational investment bank and financial services company
- The Trump administration threatens tariffs on Switzerland, leading Switzerland to seek a new trade agreement with the US.Mon 00:13
- Following the acquisition of Credit Suisse, the Swiss parliament proposed new banking regulations for UBS.Sun 10:25

Coverage

Newest first; wire copies grouped

Jun 27Unknown outlet